Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Congenital amegakaryocytic thrombocytopenia (CAMT) is an inherited disorder characterized at birth by thrombocytopenia with reduced megakaryocytes, which evolves into generalized bone marrow aplasia during childhood. Although CAMT is genetically heterogeneous, mutations of
MPL
, the gene encoding for the receptor of thrombopoietin (THPO), are...
Alternative Titles
Full title
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ffa6e09fb47b43f7a5759bea3164de2e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ffa6e09fb47b43f7a5759bea3164de2e
Other Identifiers
ISSN
1757-4676
E-ISSN
1757-4684
DOI
10.15252/emmm.201708168
